Therapeutic hydroxyquinolones

US9701638B2 · kind B2 · utility

Assignee

• Rutgers, the State University of New Jersey · US

Inventors

• Edmond J. LaVoie · Princeton Junction, US
• Joseph David Bauman · New Brunswick, US
• Hye Yeon Sagong · New Brunswick, US
• Eddy Arnold · New Brunswick, US
• Ajit Parhi · New Brunswick, US
• Kalyan Das · Edison, US
• Suyambu Kesava Vijayan · New Brunswick, US
• Disha Patel · New Brunswick, US

Key dates

• Filing date: Nov 8, 2013
• Grant date: Jul 11, 2017
• Expiry date: Nov 8, 2033

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D401/14
• WIPO field: Organic fine chemistry
• WIPO sector: Chemistry

Abstract

The invention provides compounds of formula (I) and salts thereof wherein R4-R8 have any of the meanings defined in the specification, as well as pharmaceutical compositions comprising the compounds or salts and methods for their use in therapy. The compounds have useful antiviral properties.